Overview of authorized drug products for subcutaneous administration: Pharmaceutical, therapeutic, and physicochemical properties Read More »
Physiological based pharmacokinetic and biopharmaceutics modelling of subcutaneously administered compounds–an overview of in silico models Read More »
How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example Read More »
Population pharmacokinetic analysis of tepotinib, an oral MET kinase inhibitor, including data from the VISION study. Cancer Chemotherapy and Pharmacology. 2022 Apr 6:1-5. Read More »
A quantitative approach to the choice of number of samples for percentile estimation in bootstrap and visual predictive check analyses Read More »
Population pharmacokinetics and exposure-response relationships of astegolimab in patients with severe asthma Read More »
Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes Read More »
Caplacizumab Model-Based Dosing Recommendations in Pediatric Patients With Acquired Thrombotic Thrombocytopenic Purpura Read More »
Modeling restoration of gefitinib efficacy by co-administration of MET inhibitors in an EGFR inhibitor-resistant NSCLC xenograft model: A tumor-in-host DEB-based approach Read More »
